Skip to content

Heavy Lifting Strength Training in Head and Neck Cancer Survivors

Feasibility and Safety of Heavy Lifting Strength Training in Head and Neck Cancer Survivors Post-Surgical Neck Dissection

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04554667
Acronym
LIFTING
Enrollment
9
Registered
2020-09-18
Start date
2020-11-24
Completion date
2022-07-31
Last updated
2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of Head and Neck

Keywords

surgery, neck dissection, strength training, survivors, exercise

Brief summary

The LIFTING trial will examine the feasibility and safety of a heavy lifting strength training (HLST) program in head and neck cancer survivors (HNCS) at least 1 years post surgical neck dissection. The trial will determine whether this training style is safe and feasible in HNCS. Physical and psychosocial changes will also be reported.

Detailed description

RATIONALE Despite improvements in treatments, HNCS still endure numerous acute and chronic side effects. Strength training has been shown to manage some of these side effects but most interventions have involved light-to-moderate resistance training programs. HLST may produce better outcomes but it is unknown if such a weight training program is feasible and safe for HNCS. OBJECTIVE The primary aim of this proposed study is to examine the feasibility and safety of a HLST program in HNCS at least 1 year post-surgical neck dissection. METHODS This single arm feasibility study will recruit 15-20 HNCS to complete the HLST program 2 times per week. The primary feasibility outcomes will include the eligibility rate (with reasons for ineligibility), recruitment rate (with reasons for refusal), 1 repetition maximum testing rate (with reasons for not completing the test), program adherence (including attendance, dose modifications, and progression), and follow-up assessment rate (with reasons for drop out). The primary efficacy outcome will be strength gains from baseline. Secondary efficacy outcomes will include physical functioning, quality of life, fear of cancer recurrence, pain, body composition, anxiety, fatigue, stress, shoulder mobility, self-esteem, sleep, and motivation to engage in a HLST program. SIGNIFICANCE Weight training is an effective intervention in HNCS but the optimal weight training prescription is unknown. If heavy weight training is deemed safe and feasible in HNCS, it can be compared to light-to-moderate load weight training to determine if it is a better prescription for improving outcomes that are important to HNCS.

Interventions

BEHAVIORALExercise Intervention

Heavy Lifting Strength Training

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Single arm, safety and feasibility trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* previously diagnosed with any subtype and stage of head and neck cancer * at least one year post surgical neck dissection for head and neck cancer and showing full shoulder range of motion or recovery of the spinal accessory nerve * adults ages 18 and older * no unmanaged medical conditions, alcohol, and drug abuse * approved for a heavy lifting strength training program by the treating surgeon and a certified exercise physiologist * ability to understand and communicate in English

Exclusion criteria

* having comorbidities or uncontrolled medical conditions that their referred clinicians indicate as inappropriate to participate in exercise

Design outcomes

Primary

MeasureTime frameDescription
Recruitment RateOver 12 weeksRecruitment rate (with reasons for refusal). Recruitment minimum: 15 participants Recruitment maximum: 20 participants Higher number= better and more data
Muscular StrengthChanges from baseline to 12 weeksChange in muscular strength from baseline to postintervention with be assessed using maximal strength tests. Minimum: none Maximum: none Higher score= better strength
Program AdherenceOver 12 weeksProgram adherence minimum: 80% Program adherence maximum: 100% Higher score= better adherence

Secondary

MeasureTime frameDescription
Waist to hip ratio (body composition)Changes from baseline to 12 weeksAssessed using waist to hip ratio (WHR) measure. Minimum WHR: none Maximum WHR: none Higher score WHR= worse body composition
AnxietyChanges from baseline to 12 weeksAssessed using the Spielberger State Trait Anxiety Inventory (STAI) Minimum: 20 Maximum: 80 Higher score= worse anxiety
FatigueChanges from baseline to 12 weeksAssessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) questionnaire Minimum: 0 Maximum: 52 Higher score=worse fatigue
StressChanges from baseline to 12 weeksAssessed using the Perceived Stress Scale (PSS) Minimum: 0 Maximum: 56 Higher score=worse perceived stress
Shoulder MobilityChanges from baseline to 12 weeksChanges in shoulder mobility Minimum: 150 degrees (18-50 years); 130 degrees (over 50 years) Maximum: none Higher score= better mobility
Self-EsteemChanges from baseline to 12 weeksChanges in level of self-esteem assessed using Rosenberg Self-Esteem (RSE) scale Minimum: 10 Maximum: 40 Higher score= better self-esteem
Physical functioningChanges from baseline to 12 weeksAssessed using the Neck Dissection Impairment Index (NDII) and maximum strength tests. Minimum: 40 Maximum: 100 Higher score= worse impairment
MotivationChanges from baseline to 12 weeksQuestions based on the theory of planned behaviour Minimum: 7 Maximum: 35 Higher score= better motivation
Cancer specific quality of lifeChanges from baseline to 12 weeksAssessed using the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N Symptom Index) Minimum: 0 Maximum: 40 Higher score= worse head and neck cancer symptoms
Cancer Symptom BurdenChanges from baseline to 12 weeksAssessed using the revised Edmonton Symptom Assessment System (ESAS-r) Minimum: 0 Maximum: 100 Higher score= worse cancer symptoms
HeightChanges from baseline to 12 weeksAssessed using standing height without shoes. Minimum height: none Maximum height: none Taller: not specifically better or worse
WeightChanges from baseline to 12 weeksAssessed using a digital scale without shoes. Minimum weight: none Maximum weight: none Higher weight: typically worse, but depends on other factors (ie. height, muscle mass, overall health status)
SleepChanges from baseline to 12 weeksChanges in sleep patterns assessed using the insomnia severity index (ISI) Minimum: 0 Maximum: 28 Higher score= worse insomnia
Fear of cancer recurrenceChanges from baseline to 12 weeksAssessed using the Fear of Cancer Recurrence Inventory (FCRI) Minimum: 0 Maximum: 36 Higher score= worse fear of cancer recurrence
Post Traumatic Growth after cancerChanges from baseline to 12 weeksHow cancer has changed an individual's life will be assessed using the Post Traumatic Growth Inventory (PTGI) Minimum: 0 Maximum: 105 Higher score= better (positive) post traumatic growth transformation

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026